Skip to main content
Erschienen in: BMC Pregnancy and Childbirth 1/2015

Open Access 01.12.2015 | Research article

Frequency, risk factors and feto-maternal outcomes of abruptio placentae in Northern Tanzania: a registry-based retrospective cohort study

verfasst von: Godwin S. Macheku, Rune Nathaniel Philemon, Olola Oneko, Pendo S. Mlay, Gileard Masenga, Joseph Obure, Michael Johnson Mahande

Erschienen in: BMC Pregnancy and Childbirth | Ausgabe 1/2015

Abstract

Background

Abruptio placentae remains a major cause of maternal and perinatal morbidity and mortality in developing countries. Little is known about the burden of abruptio placentae in Tanzania. This study aimed to determine frequency, risk factors for abruptio placentae and subsequent feto-maternal outcomes in women with abruptio placentae.

Methods

We designed a retrospective cohort study using maternally-linked data from Kilimanjaro Christian Medical Centre (KCMC) medical birth registry. Data on all women who delivered live infants and stillbirths at 28 or more weeks of gestation at KCMC hospital from July 2000 to December 2010 (n = 39,993) were analysed. Multivariate logistic models were used to calculate odds ratios (OR) and 95 % confidence intervals (CIs) for risk factors, and feto-maternal outcomes associated with abruptio placentae.

Results

The frequency of abruptio placentae was 0.3 % (112/39,993). Risk factors for abruptio placentae were chronic hypertension (OR 4.1; 95 % CI 1.3–12.8), preeclampsia/eclampsia (OR 2.1; 95 % CI 1.1–4.1), previous caesarean delivery (OR 1.3; 95 % CI 1.2–4.2), previous abruptio placentae (OR 2.3; 95 % CI 1.8–3.4), fewer antenatal care visits (OR 1.3; 95 % 1.1–2.4) and high parity (OR 1.4; 95 % CI 1.2–8.6). Maternal complications associated with abruptio placentae were antepartum haemorrhage (OR 11.5; 95 % CI 6.3–21.2), postpartum haemorrhage (OR 17.9; 95 % 8.8–36.4),), caesarean delivery (OR 5.6; 95 % CI 3.6–8.8), need for blood transfusions (OR 9.6; 95 % CI 6.5–14.1), altered liver function (OR 5.3; 95 % CI 1.3–21.6) and maternal death (OR 1.6; 95 % CI 1.5–1.8). In addition, women with abruptio placentae had prolonged duration of hospital stay (more than 4 days) and were more likely to have been referred during labour. Adverse fetal outcomes associated with abruptio placentae include low birth weight (OR 5.9; 95 % CI 3.9–8.7), perinatal death (OR 17.6; 95 % CI 11.3–27.3) and low Apgar score (below 7) at 1 and 5 min.

Conclusions

Frequency of abruptio placentae is comparable with local and international studies. Chronic hypertension, preeclampsia, prior caesarean section delivery, prior abruptio placentae, poor attendance to antenatal care and high parity were independently associated with abruptio placentae. Abruptio placentae was associated with adverse maternal and foetal outcomes. Clinicians should identify risk factors for abruptio placentae during prenatal care when managing pregnant women to prevent adverse maternal and foetal outcomes.
Hinweise

Competing interests

The authors declared that they have no competing interests.

Authors’ contributions

MSG designed the study and performed the statistical analysis and participated in the writing of the manuscript; RNP, JO, OO and MSP contributed in reviewing the manuscript for intellectual content; MG Participated in drafting the manuscript and review. MJM performed the statistical analysis and participated to the writing of the manuscript. All authors read and approved the final manuscript.

Background

Abruptio placentae is defined as placental detachment before and during delivery [1]. It occurs in about 0.38–1 % of singleton births, and the incidence increases among twin pregnancies, ranging from 1 to 2 % [2, 3]. It is a major obstetric complication associated with an increased risk of foetal and maternal morbidity and mortality globally, especially in developing countries [1, 46]. Over 50 % of all perinatal deaths attributed to abruptio placentae pregnancies are accompanied by premature delivery [7]. In addition, abruptio placentae accounts for 20–25 % of antepartum haemorrhages, and it is also associated with an increased risk of disseminated intravascular coagulopathy, severe maternal shock, renal failure [1, 8], postpartum haemorrhage and maternal death [1, 9, 10]. Furthermore, abruptio placentae has been associated with adverse foetal outcomes including low birth weight, preterm birth, intrauterine growth restriction, birth asphyxia, fetal distress, low apgar score, transfer to neonatal intensive care unit, stillbirth [1, 1012], congenital anomalies and perinatal death ranging from 4.4 to 67.3 % [1, 9, 13].
Several risk factors have been associated with abruptio placentae including previous history of small-for gestational age delivery, young or advanced maternal age (<20 years or >=35 years), previous history of abruptio placentae, previous history of caesarean section, maternal headaches/migraine, current diabetes mellitus, multiparity (especially grand multiparity), maternal cigarette smoking, multiple gestations, chronic hypertension, preeclampsia, premature rupture of membranes, thrombophilic disorders, abdominal trauma and polyhydramnios [4, 9, 1421].
Most studies on abruptio placenta have been reported in developed countries, there are limited reports from Tanzania and the East African region. Given the high background risk of African women coupled with weak health care system, some women in Africa might carry an exceptionally high risk of abruptio placentae as compared to women in developed countries and may benefit from preventive interventions thus the need to identify those at risk. The objective of this study was to determine the frequency, risk factors for abruptio placentae and feto-maternal outcomes associated with abruptio placentae in Tanzania.

Methods

Study setting

This study was conducted at Kilimanjaro Christian Medical Centre (KCMC) in Northern Tanzania. KCMC is one among the four zonal referral hospitals in Tanzania. It is located in Moshi Municipality in Northern Tanzania. The catchment area of the hospital captures the regions Kilimanjaro, Arusha, Manyara and Tanga, although most deliveries it taking place at the hospital are from the Kilimanjaro region. Annually, around 4000 deliveries are conducted at KCMC. The KCMC medical birth registry was established in 1999 as a collaborative project between KCMC through Kilimanjaro Christian Medical University College and the medical birth registry of Norway through University of Bergen, and it has been in operation since 2000. From this period, information regarding all deliveries that occur in the department of Obstetrics and Gynaecology at KCMC is collected.

Study design

A retrospective cohort study was designed using maternally-linked data from KCMC-medical birth registry. A unique hospital identification number which was assigned to each woman at first admission was used to trace her medical records for later admissions. This identification number was included in the registry’s record of each birth and was used to link records of successive births of the same woman. This enabled us to create historic cohort of women who delivered at the hospital from July, 2000 to December, 2010 (n = 40, 504). All women with 28 or more weeks of gestation were included. We excluded all patients diagnosed with placentae previa, pathology of lower genital tract, patients who had bleeding disorders (i.e. maternal bleeding disorders unrelated to the effect of abruptio placentae) and those with missing record on abruptio placentae status (n = 511). The remaining 39,993 births (112 abruptio placentae case and 39,881 non-abruptio placentae) were analysed (Fig. 1).

Data collection

Information for all women who delivered at Obstetrics and Gynaecology unit was recorded at the medical birth registry in a computerized data base. Trained midwives conducted an interview for all mothers who delivered on daily basis using a standardized questionnaire within 24 h of delivery (or later in case a mother experienced some complications). In addition, women were asked to bring with their antenatal care card for information verification regarding pregnancy history. A verbal consent was sought from all mothers prior to the interview. Finally, all data was entered into the database at the medical birth registry.
The following information was collected from the mothers: Details on mother’s and father’s socio-demographic factors including occupation, education, age, marital status, alcohol and smoking during pregnancy, body mass index variables (pregnancy and the end of pregnancy). Details on obstetric characteristics as well as medical complications included pre-pregnancy conditions, mother’s conditions during pregnancy and after delivery. Information on pregnancy outcome include child status, still birth, birth weight and gestational age. The duration of hospital stay was calculated as the number of days from admission to the discharge date.

Diagnosis of abruptio placentae

Diagnosis of abruptio placentae was based on routine clinical examination and ultrasound performed by the attending physician. The diagnosis was based on evidence of retroplacental clot accompanied by features clinical features such as vaginal bleeding, abdominal pain, abdominal tenderness, hypertonic uterus and hard abdomen with the fundal height greater than the gestational age accompanied.

Definition of outcome measures

Postpartum haemorrhage was defined as loss of blood estimated to be more than 500 mls from the genital tract, within 24 h of delivery. Acute renal failure was defined as an abrupt loss of kidney function resulting in the retention of urea and other nitrogenous waste products and in the dysregulation of extracellular volume and electrolytes.
Preterm birth was defined as a birth occurring at less than 37 completed weeks of gestation. Perinatal death was defined as fetal death that occurred inutero after a gestation age of 28 weeks or more (stillbirth), plus infant death that occurred at less than 7 days of age post delivery (early neonatal death). Low birth weight infant was defined as an infant having birth weight less than 2500 g. Fetal distress was defined as a compromised condition of the fetus, discovered during labor or intrapartum period characterized by a markedly abnormal heart rate or rhythm. Apgar score was defined as a measure of the physical condition of a newborn infant. It is obtained by adding points (2, 1, or 0) for heart rate, respiratory effort, muscle tone, response to stimulation, and skin coloration; a score of ten represents the best possible condition. Pathology of lower genital tract was defined as lower genital tracts lesions presenting with vaginal bleeding or spotting. Abdominal trauma was defined as blunt abdominal injury.
This study was approved by the Kilimanjaro Christian Medical University College Research Ethics Committee. The informed consent was obtained from all women prior the interview after they were fully explained the aim of the medical birth registry project. As for this study, informed consent was not requested as we used data from already approved project. Furthermore, confidentiality and privacy was assured according to the birth registry protocol.

Statistical analysis

Data analysis was performed using Statistical package for Social Science (SPSS) program (SPSS Inc. Chicago, III) version 17.0. Maternal age was normally distributed, thus the difference in maternal age was assessed using student-t test. The differences involving categorical variable were assessed by chi-square test. Odds ratios (ORs) with 95 % confidence intervals (CIs) for the risk factors associated with abruptio placentae and maternal-foetal outcome were estimated in a multivariable logistic regression. A P-value of less than 0.05 (2-tailed) was considered to be statistically significant.
A variable was considered as a possible confounder if its inclusion in the model changed odds ratio of the independent variable of interest by at least 10 %. We considered the following variables as possible confounders in our analysis: maternal age, marital status, parity, alcohol use during pregnancy and area of residence.

Results

Demographic and obstetric characteristics of the study participants

A total of 39,993 deliveries were analysed. The incidence of abruptio placentae during the study period was 0.3 % (112/39,993). Demographic and obstetric characteristics of the participants are described in Table 1. Women with abruptio placentae had significantly higher mean age as compared to women without abruptio placentae, (29.1(SD = 5.4) vs.27.5 (SD = 6.0); P = 0.004, respectively). Married women and those who reported residing in rural areas were all at increased risk for abruptio placentae. Furthermore, the proportion of abruption increased with increasing education level and parity, although an association with maternal smoking and alcohol consumption during pregnancy was not significant.
Table 1
Demographic and obstetric characteristics of the study participants
Maternal characteristics
Placental abruption (N = 112; %)
No placental abruption (n =39,881; %)
P value*
Maternal agea
29.1 (5.4)
27.5 (6.0)
0.004
Maternal age (years)
  
0.02
 <20
12 (10.7)
3528 ((8.8)
 
 20–34
80 (71.4)
30,782 (77.3)
 
 ≥35
20 (17.9)
5571 (13.9)
 
Marital status
  
0.03
 Married
107 (95.5)
35,549 (89.1)
 
 Single
5 (0.5)
4332 (10.9)
 
Mother’s area of residence
   
 Rural
61 (54.5)
16,995 (42.6)
0.01
 Urban
51 (45.5)
22,886 (57.4)
 
Smoking in current pregnancy
  
1.00
 Yes
0 (0)
44 (0.1)
 
 No
112 (100)
39,837 (99.9)
 
Alcohol use during pregnancy
  
0.12
 Yes
44 (38.4)
12,679 (31.8)
 
 No
68 (60.7)
27,202 (68.2)
 
Mother’s educational (years)
  
0.001
 <12
87 (77.7)
25,081 (62.9)
 
 ≥12
25 (22.3)
14,800 (37.1)
 
Antenatal care (ANC)
  
0.54
 Yes
111 (99.1)
39,607 (99.3)
 
 No
1 (0.9)
274 (0.7)
 
Gravidity
  
<0.001
 1
22 (19.6)
12,105 (30.4)
 
 2–4
67 (59.8)
24,618 (61.7)
 
 ≥5
23 (20.6)
3158 (7.9)
 
Parity
  
<0.001
 0
24 (21.4)
13,056 (32.7)
 
 1–4
76 (67.9)
25,777 (64.6)
 
 ≥5
12 (10.7)
1048 (2.6)
 
amean and standard deviation
*P value calculated from chi square

Risk factors for abruptio placentae

The results from multivariate logistic model for risk factors associated with abruptio placentae are summarized in Table 2. The risk factors of abruptio placentae in this population were chronic hypertension (OR 4.1; 95 % CI 1.3–12.8), preeclampsia/eclampsia (OR 2.1; 95 % CI 1.1–4.1), prior caesarean section delivery (OR 1.3; 95 % CI 1.2–4.2), previous abruptio placentae (OR 2.3; 95 % CI 1.8–3.4). Similarly, women complicated by abruption placentae were more likely to have less than 4 antenatal care visits (OR 2.1, 95 % CI 1.2–2.5), multigravida (OR 2.1; 95 % CI 1.2–3.5) and high parity (OR 1.4; 95 % CI 1.2–8.6). Other known risk factors for abruptio placentae such as multiple gestations and male infant gender were not significantly associated with abruptio placentae in this population.
Table 2
Risk factors associated with placental abruption
Risk factors
Placental abruption (N = 112; 0.3 %)
No abruption (N =39,881; 99.7 %)
Unadjusted OR (95 % CI)
Adjusted OR (95 % CI)a
Chronic hypertension
  
4.5 (1.6–13.2)
4.1 (1.3–12.8)
 Yes
3 (1.1)
269 (98.9)
  
 No
109 (0.3)
39,612 (99.7)
  
Preeclampsia/eclampsiab
  
2.5 (1.6–5.2)
2.1 (1.1–4.1)
 Yes
9 (0.6)
1622 (99.4)
  
 No
103 (0.3)
38,259 (99.7)
  
Multiple gestations
 Yes
106 (0.28)
37,664 (99.7)
1.0 (0.5–2.3)
0.8 (0.3–1.9)
 No
6 (0.27)
2217(99.7)
  
Previous caesarean -section
  
1.5 (1.2–4.8)
1.3 (1.2–4.2)
 Yes
22 (0.3)
6947 (99.7)
  
 No
90 (0.12)
32,934 (99.8)
  
Previous abruptio placentaec
  
3.8 (2.3–6.4)
2.3 (1.8–3.4)
 Yes
49 (0.7)
6658 (99.3)
  
 No
63 (0.19)
33,223 (99.8)
  
Antenatal care visits
  
1.6 (1.2–2.6)
1.3 (1.1–2.4)
 <4
53 (0.4)
13,315 (99.6)
  
 ≥4
59 (0.2)
26,566 (99.8)
  
Gravidity
  
2.2 (1.4–3.6)
2.1 (1.2–3.5)
 Multigravida
90 (0.3)
27,766 (99.7)
  
 Primigravida
22 (0.18)
12,115 (99.8)
  
Parity
  
1.7 (1.4–10.5)
1.4 (1.2–8.6)
 ≥2
65 (0.36)
17,836 (99.6)
  
 <2
47 (0.2)
22,045 (99.8)
  
Sex of the baby
 Male
62 (0.3)
20,580 (99.7)
1.2 (0.9–1.7)
1.03(0.7–1.5)
 Female
50 (0.25)
19,301 (99.75)
  
aAdjusted for maternal age, maternal education level, marital status, area of residence
bAdjusted for previous abruptio placentae and chronic hypertension
cAdjusted for previous caesarean section delivery

Maternal outcomes associated with abruptio placentae

Findings from logistic regression model for maternal outcomes associated with abruptio placentae are illustrated in Table 3. Compared with women without abruption, those with abruptio placentae had increased risk of antepartum haemorrhage (OR 11.5; 95 % CI 6.3–21.2), postpartum haemorrhage (OR 17.9; 95 % CI 8.8–36.4), caesarean section delivery (OR 5.6; 95 % CI 3.6–8.8) and need for blood transfusions (OR 9.6; 95 % CI 6.5–14.1). Similarly, women with abruptio placentae were more likely to have prolonged hospital stay (OR 3.5; 95 % CI 1.4–8.6) compared with those who had no abruptio placentae. Furthermore, abruptio placentae increased women’s likelihood of having been referred during labour (OR 3.8, 95 % CI 1.5–9.2). Our data also show that, women whose pregnancies were complicated by abruptio placentae had increased risks of altered liver function (OR 5.3, 95 % CI 1.3–21.6) and (OR 1.6; 95 % CI 1.5–1.8). There were four maternal deaths which were related to postpartum haemorrhage, corresponding to case fatality rate of 3.6 % (6/112). Moreover, patients with abruptio placentae had increased odds for induced labour as well as being transferred to intensive care unit, but the association did not reach statistical significance.
Table 3
Multiple logistic regression of maternal outcomes associated with abruptio placentae
Maternal outcomes
Abruption placental (n = 112)
No abruption (n =39,881)
Unadjusted OR (95 % CI)
Adjusted OR (95 % CI)a
Antepartum haemorrhage
 Yes
13(3.0)
420 (97.0)
11.9 (6.5–21.8)
11.5 (6.3–21.2)
 No
99 (0.3)
39,461 (99.7)
1.0
1.0
Postpartum haemorrhage
 Yes
10 (7.6)
145 (92.4)
25.6 (12.4–52.8)
17.9 (8.8–36.4)
 No
100 (0.3)
39,736 (99.7)
1.0
1.0
Model of delivery
 Caesarean delivery
85 (0.7)
12,914 (99.3)
6.6 (4.3–10.1)
5.6 (3.6–8.8)
 Vaginal delivery
27 (0.1)
26,967 (99.9)
1.0
1.0
Acute renal failure
 Yes
1 (0.6)
153 (99.4)
2.4 (0.6–16.3)
2.2 (0.3–15.5)
 No
111 (0.3)
39,728 (99.7)
1.0
1.0
Need for blood transfusion
 Yes
43 (1.9)
2248 (98.1)
10.1 (6.9–14.8)
9.6 (6.5–14.1)
 No
69 (0.2)
37,633 (99.7)
1.0
1.0
Duration of hospitalization
 >4 days
18 (1.3)
1415 (98.7)
5.2 (2.3–15.4)
3.5 (1.8–9.6)
 ≤4 days
94 (0.2)
38,466(99.7)
1.0
1.0
Referred for delivery
 Yes
46 (0.5)
8841 (99.5)
2.3 (1.6–9.5)
2.1 (1.5–8.2)
 No
66 (0.2)
31,040 (99.8)
1.0
1.0
Altered liver function test
 
2 (1.5)
128 (98.5)
5.6 (1.4–22.9)
5.3 (1.3–21.6)
 
110 (0.3)
39,753 (99.7)
1.0
1.0
Admission to NICU
 Yes
23 (0.4)
5667 (99.6)
1.6 (1.2–2.5)
1.5 (0.9–2.4)
 No
89 (0.3)
34,214 (99.7)
1.0
1.0
Multiple logistic regression with back ward elimination of maternal outcomes associated with placental abruption
aAdjusted for preeclampsia/eclampsia, chronic hypertension

Fetal outcomes associated with abruptio placentae

The foetal outcomes associated with abruptio placentae have been summarized in Table 4. After adjustment for confounding variables, infants born to women with abruptio placentae had increased risk of low birth weight (OR 5.9; 95 % CI 3.9–8.7), perinatal death (OR 17.6; 95 % CI 11.3-27-3), early neonatal death (OR 5.3; 95 % CI: 3.8–17.9) and stillbirth (OR 23.7; 15.6–35.9) especially fresh stillbirth (OR 2.5; 95 % CI 1.5–4.2). In addition, infants born to women with abruptio placentae had increased risk of low Apgar scores (below 7) at 1st and 5th min with ORs of 5.3 (95 % CI 2.7–10.1) and 2.2 (95 % CI 0.9–4.8), respectively as compared to infants born to mothers without abruptio placentae. The association between abruptio placentae with preterm birth and fetal distress was not statistically significant. Overall, abruptio placentae contributed to perinatal mortality rate of 40 per 1000 births (74/1826).
Table 4
Multiple logistic regression of foetal outcomes associated with abruptio placentae
Fetal outcomes
Abruption placenta
Non abruption
Unadjusted OR (95 % CI)
Adjusted OR (95 % CI)a
P value
Low birth weight
 Yes
56 (1.1)
5269 (98.9)
6.9 (4.7–10.1)
5.9 (3.9–8.7)
<0.001
 No
56 (0.2)
34,612(99.8)
1.0
1.0
 
Perinatal death
 Yes
63 (3.5)
1762(96.5)
28.9 (19.8–42.1)
17.6 (11.3–27.3)
<0.001
 No
49 (0.1)
38,119(99.9)
1.0
1.0
 
Early neonatal death
 Yes
5 (1.5)
315 (98.5)
5.5 (2.1–15.2)
4.3 (1.8–9.9)
0.001
 No
107 (0..3)
39,566(99.8)
1.0
1.0
 
Stillbirthb
 Yes
58 (3.8)
1473 (96.2)
28.0 (19.3–40.7)
23.7 (15.6–35.9)
<0.001
 No
54 (0.1)
38,408(99.9)
1.0
1.0
 
Stillborn conditionc
 Fresh
37 (7.2)
475 (92.8)
4.6 (2.2–9.7)
2.5 (1.5–4.2)
<0.001
 Macerated
9 (1.9)
534 (98.3)
1.0
1.0
 
Preterm birth
 Yes
30 (0.2)
4473 (99.8)
2.9 (1.1–7.4)
0.4 (0.1–7.1)
0.97
 No
82 (0.3)
35,408(99.7)
1.0
1.0
 
Fetal distress
 Yes
22 (0.3)
6947 (99.7)
1.2 (0.5–3.6)
0.8 (0.2–3.1)
0.69
 No
90 (0.1)
32,934 (99.9)
1.0
1.0
 
Apgar score at 1 min
 <7
41 (1.1)
3810 (98.9)
5.4 (3.6–12.3)
5.3(2.7–10.1)
<0.001
 ≥7
71 (0.2)
36,071(99.8)
1.0
 
1.0
Apgar score at 5 min
 <7
18 (0.7)
2292 (97.1)
2.9 (1.2–5.3)
2.2 (0.9–4.8)
0.054
 ≥7
94 (0.2)
37,589 (99.9)
1.0
1.0
 
Multiple logistic regression with back ward elimination of perinatal outcomes associated with placental abruption
aAdjusted for parity and antenatal care visits chronic hypertension and preeclampsia
bAdjusted for stillborn condition3
cdoes not add to to tota because of missing values

Discussion

Main findings

In this study, we found that the incidence of abruptio placentae was 0.3 %. The risk factors for abruptio placentae were chronic hypertension, preeclampsia/eclampsia, previous caesarean delivery or abruptio placentae, poor attendance to antenatal care and high parity. Patients with abruptio placentae had increased risk of adverse maternal and foetal outcomes. Post-partum haemorrhage was an important predictor maternal deaths.

Comparison with previous studies

The incidence of abruptio placentae in our study corresponds with incidence of 0.34 % which has been reported previously [18]. This figure also falls within the range of 0.3–2 %, reported by others [2, 3, 8, 13], but it is lower than what has been reported previously in Uganda and Israel [22, 23]. The difference in incidence could partly be explained by the differences in the studied populations, study designs and diagnostic criteria.
Previous studies reported the association between increased risk of abruptio placentae with chronic hypertension [19, 22, 2426] and preeclampsia/eclampsia [15, 21, 25, 2729]. Our results are in general agreement with previous reports, but they are contrast with that was reported by Wandabwa and colleagues [22], who observed that neither severity of blood pressure nor proteinuria were predictive factors of abruptio placentae. The possible reason for difference in findings could be explained by differences in nature of the studied populations and prevalence of these risk factors.
The second important finding of our study pertains to the association between previous caesarean delivery and increased risk of abruptio placentae. The risk of abruptio placentae increased by nearly 2-fold for women with prior caesarean section delivery. Similar observation was reported elsewhere [1820, 30], but in our study was lower than the seven and ten-fold reported by Wandabwa et al. and Nayama et al. [22, 31]. The increased risk of abruption among women with prior caesarean delivery may imply that these women had ruptured scar from the previous caesarean. The differences in risk of abruption placentae between our study and those of others may be explained by the differences in pre-existing conditions which are associated with abruptio placentae between the studied populations.
Our study confirmed that abruptio placentae in a previous pregnancy is an important risk factor for abruptio placentae in subsequent pregnancies. This observation is in agreement with previous report [32]. An association between prior abruptio placentae and its recurrence in the subsequent pregnancies was demonstrated by Rasmussen and colleagues in a Norwegian cohort [33] were they reported a 5-fold increase in relative recurrence risk of abruptio placentae. This indicates that more persistent risk factors such as preeclampsia and chronic hypertension may play the role.
In the present study, the occurrence of abruptio placentae was higher in women with high parity and multigravid as compared to nulliparous or primigravid women. These results are in line with many previous studies [24, 25, 3438], but was in contrast with findings of Sanchez and colleagues [21] who observed that neither of these factors were associated with abruptio placentae.
Previous studies have reported that both maternal cigarette smoking [4, 5] and alcohol consumption during pregnancy [27, 28, 39] are associated with abruptio placentae. In contrast to our study, these variables were not associated with abruptio placentae. The proportion of those who smoked was too low to assess the influence of smoking on abruptio placentae. Furthermore, lack of association between alcohol consumption and abruption placentae may in part be explained by the variation in amount, type and mode of alcohol used by participants between studies.
The occurrence of abruptio placentae has been associated with an increased risk of maternal and foetal morbidity and mortality in previous studies [1, 3, 6, 22]. In line with our study, women with abruptio placentae had 12-fold higher risk of postpartum haemorrhage as compared to women in the comparison group. Similarly, Sarwar and colleagues in Pakistan [10], reported that 22.2 % of the abruptio placentae patients experienced severe postpartum haemorrhage as a result of uterine atony, coagulation failure, or puerperal sepsis. However, it is worth noting that the diagnosis of abruptio placentae is subject to misclassification and is recorded with knowledge of the outcome of pregnancy. Therefore, pregnancy with severe haemorrhage may be more likely to be recorded as abruptio placentae if the baby dies. This in part could be a possible explanation for increased risk of postpartum haemorrhage attributed to abruptio placentae in our study.
The observed maternal death rate related to abruptio placentae in our study is above the maximum acceptable rate of 1 % [7], but the case fatality rate is lower than the 4.7 % that was reported by Seema et al. [6].
In our study, women with pregnancies complicated by abruptio placentae had six-fold risk of delivering an infant with low birth weight as compared to women in the control group. Similar finding was reported in Uganda [22]. The high risk of low birth weight delivery among women with abruptio placentae may be explained by the effect of preterm birth due to premature termination of pregnancy performed by clinicians due to severity of abruptio placentae or effect of intrauterine foetal growth retardation. The risks of stillbirth, early neonatal death and perinatal death were also higher among women with abruptio placentae as compared to women without abruptio. These results are in congruent with previous studies [1, 6, 9, 13, 21, 23]. It has been previously reported that the magnitude of stillbirth is dependent on the degree of separation of placentae, particularly when it exceeds 50 % [12]. This could be the case for some women in the present study, which in turn could be the reason for the observed high risk of perinatal death and its components. However, the observed excess risk in perinatal death may also likely to be caused by prematurity and intrauterine foetal growth restriction. It is worth noting that the perinatal mortality rate observed in our study is higher than 25.6 per 1000 deliveries reported elsewhere [6].
Previous investigators reported an increased risk of preterm birth among women with abruptio placentae [9]. However, this was not the case in our study. The association between abruptio placentae and preterm birth disappeared after adjustment for covariates in the model. Furthermore, patients with abruptio placentae were more likely to deliver a baby with low Apgar score at 1st and 5th minutes respectively. The high risk of low Apgar score may be due to prematurity, while on the other hand it may be an indication of lack equipment/supplies and lifesaving skills of new-borns who are born preterm/low birth weight in the study setting.

Strengths and limitations of the study

The strength of this study is that we used maternally linked data which containing detailed information on paternal and maternal social demographic, mother’s information before and during pregnancy, labour and after delivery as well as new-born status. This information allowed us to examine the reproductive history of all women in the cohort over a 10 year period, thus providing an adequate sample size to examine with high precision for a relatively uncommon outcome. Secondly, the linked data also allowed us to measure and take into account the influence of important reproductive factors that confound the association between abruptio placentae and the studied outcomes thus avoiding overestimation of the reported risks. Third, we used data which was collected using a standardized questionnaire thus enhancing the quality of our data.
This study has some weakness. First, possibility of selection bias, since this was a hospital-based study, women with complicated pregnancies are more likely to be referred for delivery in the study setting. This may lead to overestimation of the reported risk and maternal fetal outcomes.
Secondly, diagnosis of abruptio placentae was based on an assessment made by the attending obstetrician. This subjective assessment may have resulted in some misclassification; especially for the severe and milder forms of abruptio placentae. Another weakness is the possibility of underreporting perinatal mortality. The medical birth registry at KCMC only captures information for mothers who stayed in the hospital up to 7 days after delivery. Therefore a ascertainment of early neonatal death may not be complete. Early neonatal deaths that may have occurred outside the hospital within 7 days of life for mothers who were discharged earlier than 7 days were not captured in the birth registry. This may have resulted to underreporting of true perinatal death.

Conclusions

Our study confirmed that chronic hypertension, preeclampsia/eclampsia, previous caesarean delivery or abruptio placentae and high parity are independent risk factors for abruptio placentae. Abruptio placentae is associated with adverse maternal and fetal outcomes. Our results provide clinicians with import information to consider when counselling women during prenatal care about the risk factors for abruptio placentae, early identification of women at risk of abruptio placentae and develop individual follow up plan with specific intervention. Improved attendance to antenatal care and timely management of these factors may reduce the risk of abruptio placentae and associated adverse feto-maternal outcomes. Furthermore, better equipped obstetric and neonatal units to improve both maternal and perinatal outcomes in this setting are warranted.

Acknowledgements

We thank for the Norwegian Council for Higher Education Program and Development for supporting the birth registry at KCMC. We are also gratefully acknowledged for the birth registry staff for their participation in data collection. Finally, we extend our gratitude appreciation to all mothers who consented to provide information to enable this study to be done.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Competing interests

The authors declared that they have no competing interests.

Authors’ contributions

MSG designed the study and performed the statistical analysis and participated in the writing of the manuscript; RNP, JO, OO and MSP contributed in reviewing the manuscript for intellectual content; MG Participated in drafting the manuscript and review. MJM performed the statistical analysis and participated to the writing of the manuscript. All authors read and approved the final manuscript.
Literatur
1.
Zurück zum Zitat Tikkanen M. Placental abruption: epidemiology, risk factors and consequences. Acta Obstet Gynecol Scand. 2011;90(2):140–9.PubMed Tikkanen M. Placental abruption: epidemiology, risk factors and consequences. Acta Obstet Gynecol Scand. 2011;90(2):140–9.PubMed
2.
Zurück zum Zitat Ananth CV, Getahun D, Peltier MR, Smulian JC. Placental abruption in term and preterm gestations: evidence for heterogeneity in clinical pathways. Obstet Gynecol. 2006;107(4):785–92.PubMed Ananth CV, Getahun D, Peltier MR, Smulian JC. Placental abruption in term and preterm gestations: evidence for heterogeneity in clinical pathways. Obstet Gynecol. 2006;107(4):785–92.PubMed
3.
Zurück zum Zitat Ananth CV, Wilcox AJ. Placental abruption and perinatal mortality in the United States. AJE. 2001;153(4):332–7. Ananth CV, Wilcox AJ. Placental abruption and perinatal mortality in the United States. AJE. 2001;153(4):332–7.
4.
Zurück zum Zitat Ananth CV, Cnattingius S. Influence of maternal smoking on placental abruption in successive pregnancies: a population-based prospective cohort study in Sweden. AJE. 2007;166(3):289–95. Ananth CV, Cnattingius S. Influence of maternal smoking on placental abruption in successive pregnancies: a population-based prospective cohort study in Sweden. AJE. 2007;166(3):289–95.
5.
Zurück zum Zitat Rasmussen S, Irgens L, Dalaker K. The effect on the likelihood of further pregnancy of placental abruption and the rate of its recurrence. Br J Obstet Gynaecol. 1997;104(11):1292–5.PubMed Rasmussen S, Irgens L, Dalaker K. The effect on the likelihood of further pregnancy of placental abruption and the rate of its recurrence. Br J Obstet Gynaecol. 1997;104(11):1292–5.PubMed
6.
Zurück zum Zitat Bibi S, Ghaffar S, Pir MA, Yousfan S. Risk factors and clinical outcome of placental abruption: a retrospective analysis. JPMA. 2009;59(10):672–4. Bibi S, Ghaffar S, Pir MA, Yousfan S. Risk factors and clinical outcome of placental abruption: a retrospective analysis. JPMA. 2009;59(10):672–4.
7.
Zurück zum Zitat Carr SR. High risk pregnancy: management options. JAMA. 1995;273(3):259–60. Carr SR. High risk pregnancy: management options. JAMA. 1995;273(3):259–60.
8.
Zurück zum Zitat Hall DR. Abruptio placentae and disseminated intravascular coagulopathy. Semin Perinatol. 2009;33(3):189–95.PubMed Hall DR. Abruptio placentae and disseminated intravascular coagulopathy. Semin Perinatol. 2009;33(3):189–95.PubMed
9.
Zurück zum Zitat Jabeen M, Gul F. Abruptio placentae: risk factors and perinatal outcome. J Postgrade Med Inst. 2011;18(4):669–76. Jabeen M, Gul F. Abruptio placentae: risk factors and perinatal outcome. J Postgrade Med Inst. 2011;18(4):669–76.
10.
Zurück zum Zitat Sarwar I, Abbas A, Islam A. Abruptio placentae and its complication at Ayub Teaching Hospital Abbotabad. J Ayub Med Coll Abbottabad. 2006;18(1):27–31.PubMed Sarwar I, Abbas A, Islam A. Abruptio placentae and its complication at Ayub Teaching Hospital Abbotabad. J Ayub Med Coll Abbottabad. 2006;18(1):27–31.PubMed
11.
Zurück zum Zitat Jakobsson M, Gissler M, Paavonen J, Tapper AM. The incidence of preterm deliveries decreases in Finland. BJOG. 2008;115(1):38–43.PubMed Jakobsson M, Gissler M, Paavonen J, Tapper AM. The incidence of preterm deliveries decreases in Finland. BJOG. 2008;115(1):38–43.PubMed
12.
Zurück zum Zitat Morgan K, Arulkumaran S. Antepartum haemorrhage. Curr Obstet Gynaecol. 2003;13(2):81–7. Morgan K, Arulkumaran S. Antepartum haemorrhage. Curr Obstet Gynaecol. 2003;13(2):81–7.
13.
Zurück zum Zitat Salihu HM, Bekan B, Aliyu MH, Rouse DJ, Kirby RS, Alexander GR. Perinatal mortality associated with abruptio placenta in singletons and multiples. Am J Obstet Gynecol. 2005;193(1):198–203.PubMed Salihu HM, Bekan B, Aliyu MH, Rouse DJ, Kirby RS, Alexander GR. Perinatal mortality associated with abruptio placenta in singletons and multiples. Am J Obstet Gynecol. 2005;193(1):198–203.PubMed
14.
Zurück zum Zitat Nath CA, Ananth CV, Smulian JC, Shen-Schwarz S, Kaminsky L. Histologic evidence of inflammation and risk of placental abruption. Am J Obstet Gynecol. 2007;197(3):319.e311–6. Nath CA, Ananth CV, Smulian JC, Shen-Schwarz S, Kaminsky L. Histologic evidence of inflammation and risk of placental abruption. Am J Obstet Gynecol. 2007;197(3):319.e311–6.
15.
Zurück zum Zitat Kyrklund-Blomberg NB, Gennser G, Cnattingius S. Placental abruption and perinatal death. Paediatr Perinat Epidemiol. 2001;15(3):290–7.PubMed Kyrklund-Blomberg NB, Gennser G, Cnattingius S. Placental abruption and perinatal death. Paediatr Perinat Epidemiol. 2001;15(3):290–7.PubMed
16.
Zurück zum Zitat Rasmussen S. Abruptio placentae – relationship with other placental dysfunction related conditions. Norsk Epidemiologi. 2007;17(2):191–7. Rasmussen S. Abruptio placentae – relationship with other placental dysfunction related conditions. Norsk Epidemiologi. 2007;17(2):191–7.
17.
Zurück zum Zitat Sanchez SE, Williams MA, Pacora PN, Ananth CV, Qiu C, Aurora SK, et al. Risk of placental abruption in relation to migraines and headaches. BMC Womens Health. 2010;10:30.PubMedPubMedCentral Sanchez SE, Williams MA, Pacora PN, Ananth CV, Qiu C, Aurora SK, et al. Risk of placental abruption in relation to migraines and headaches. BMC Womens Health. 2010;10:30.PubMedPubMedCentral
18.
Zurück zum Zitat Getahun G, Oyelese Y, Salihu HM, Ananth CV. Previous Cesarean delivery and risks of placenta previa and placental abruption. Obstet Gynecol. 2006;107(4):771–8.PubMed Getahun G, Oyelese Y, Salihu HM, Ananth CV. Previous Cesarean delivery and risks of placenta previa and placental abruption. Obstet Gynecol. 2006;107(4):771–8.PubMed
19.
Zurück zum Zitat Rasmussen S, Irgens LM, Dalaker K. A history of placental dysfunction and risk of placental abruption. Paediatr Perinat Epidemiol. 1999;13(1):9–21.PubMed Rasmussen S, Irgens LM, Dalaker K. A history of placental dysfunction and risk of placental abruption. Paediatr Perinat Epidemiol. 1999;13(1):9–21.PubMed
20.
Zurück zum Zitat Lydon-Rochelle M, Holt VL, Easterling TR, Martin DP. First-birth cesarean and placental abruption or previa at second birth. Obstet Gynecol. 2001;97(5):765–9.PubMed Lydon-Rochelle M, Holt VL, Easterling TR, Martin DP. First-birth cesarean and placental abruption or previa at second birth. Obstet Gynecol. 2001;97(5):765–9.PubMed
21.
Zurück zum Zitat Sanchez SE, Pacora PN, Farfan JH, Fernandez A, Qiu C, Ananth CV, et al. Risk factors of abruptio placentae among Peruvian women. Am J Obstet Gynecol. 2006;194(1):225–30.PubMed Sanchez SE, Pacora PN, Farfan JH, Fernandez A, Qiu C, Ananth CV, et al. Risk factors of abruptio placentae among Peruvian women. Am J Obstet Gynecol. 2006;194(1):225–30.PubMed
22.
Zurück zum Zitat Wandabwa J, Doyle P, Kiondo P, Margaret A, Wandabwa A, Aziga F. Risk factors for severe abruptio placenta in Mulago Hospital, Kampala, Uganda. Afr Health Sc. 2005;5(4):285–90. Wandabwa J, Doyle P, Kiondo P, Margaret A, Wandabwa A, Aziga F. Risk factors for severe abruptio placenta in Mulago Hospital, Kampala, Uganda. Afr Health Sc. 2005;5(4):285–90.
23.
Zurück zum Zitat Sheiner E, Shoham-Vardi I, Hallak M, Hadar A, Gortzak-Uzan L, Katz M, et al. Placental abruption in term pregnancies: clinical significance and obstetric risk factors. J Matern Fetal Neonatal Med. 2003;13(1):45–9.PubMed Sheiner E, Shoham-Vardi I, Hallak M, Hadar A, Gortzak-Uzan L, Katz M, et al. Placental abruption in term pregnancies: clinical significance and obstetric risk factors. J Matern Fetal Neonatal Med. 2003;13(1):45–9.PubMed
24.
Zurück zum Zitat Ananth CV, Wilcox AJ, Savitz DA, Bowez Jr WA, Luther ER. Effects of maternal age and parity on the risk of uteroplacental bleeding disorders of pregnancy. Obstet Gynecol. 1996;88:511–6.PubMed Ananth CV, Wilcox AJ, Savitz DA, Bowez Jr WA, Luther ER. Effects of maternal age and parity on the risk of uteroplacental bleeding disorders of pregnancy. Obstet Gynecol. 1996;88:511–6.PubMed
25.
Zurück zum Zitat Williams MA, Lieberman E, Mittendorf R, Monson RR, Schoenbaum SC. Risk factors for abruptio placentae. Am J Epidemiol. 1991;134:965–72.PubMed Williams MA, Lieberman E, Mittendorf R, Monson RR, Schoenbaum SC. Risk factors for abruptio placentae. Am J Epidemiol. 1991;134:965–72.PubMed
26.
Zurück zum Zitat Kramer MS, Usher RH, Polllack R, Boyd M, Usher S. Etiologic determinants of abruptio placentae. Obstet Gynecol. 1997;89:221–6.PubMed Kramer MS, Usher RH, Polllack R, Boyd M, Usher S. Etiologic determinants of abruptio placentae. Obstet Gynecol. 1997;89:221–6.PubMed
27.
Zurück zum Zitat Hung T-H, Hsieh C-C, Hsu J-J, Lo L-M, Chiu T-H, Hsieh T-T. Risk factors for placental abruption in an Asian population. Reprod Sci J. 2007;14(1):59–65. Hung T-H, Hsieh C-C, Hsu J-J, Lo L-M, Chiu T-H, Hsieh T-T. Risk factors for placental abruption in an Asian population. Reprod Sci J. 2007;14(1):59–65.
28.
Zurück zum Zitat Tikkanen M, Nuutila M, Hiilesmaa V, Paavonen J, Ylikorkala O. Prepregnancy risk factors for placental abruption. Acta Obstet Gynecol Scand. 2006;85(1):40–4.PubMed Tikkanen M, Nuutila M, Hiilesmaa V, Paavonen J, Ylikorkala O. Prepregnancy risk factors for placental abruption. Acta Obstet Gynecol Scand. 2006;85(1):40–4.PubMed
29.
Zurück zum Zitat Tikkanen M, Nuutila M, Hiilesmaa V, Paavonen J, Ylikorkala O. Clinical presentation and risk factors of placental abruption. Acta Obstet Gynecol Scand. 2006;85(6):700–5.PubMed Tikkanen M, Nuutila M, Hiilesmaa V, Paavonen J, Ylikorkala O. Clinical presentation and risk factors of placental abruption. Acta Obstet Gynecol Scand. 2006;85(6):700–5.PubMed
30.
Zurück zum Zitat Rageth JC, Juzi C, Grossenbacher H. Delivery after previous cesarean: a risk evaluation. Swiss Working Group of Obstetric and Gynecologic Institutions. Obstet Gynecol. 1999;93(3):332–7.PubMed Rageth JC, Juzi C, Grossenbacher H. Delivery after previous cesarean: a risk evaluation. Swiss Working Group of Obstetric and Gynecologic Institutions. Obstet Gynecol. 1999;93(3):332–7.PubMed
31.
Zurück zum Zitat Nayama M, Tamakloé-Azamesu D, Garba M, Idi N, Djibril B, Kamayé M, et al. Abruptio placentae. Management in a reference Nigerien maternity. Prospective study about 118 cases during one year. Gynecol Obstet Fertil. 2007;35(10):975–81.PubMed Nayama M, Tamakloé-Azamesu D, Garba M, Idi N, Djibril B, Kamayé M, et al. Abruptio placentae. Management in a reference Nigerien maternity. Prospective study about 118 cases during one year. Gynecol Obstet Fertil. 2007;35(10):975–81.PubMed
32.
Zurück zum Zitat Cunningham GF, MacDonald PC, Gant NF, et al. eds, chapter 37. Obstetric hemorrhage. In: Williams obstetrics. 19th ed. Norwalk: Appleton & Lange; 1993. p. 819–51. Cunningham GF, MacDonald PC, Gant NF, et al. eds, chapter 37. Obstetric hemorrhage. In: Williams obstetrics. 19th ed. Norwalk: Appleton & Lange; 1993. p. 819–51.
33.
Zurück zum Zitat Rasmussen S, Irgens LM, Albrechtsen S, Dalaker K. Women with a history of placental abruption: when in subsequent pregnancy should special surveillance for a recurrent placental abruption be initiate? Acta Obstet Gynecol Scand. 2001;80(8):708–12.PubMed Rasmussen S, Irgens LM, Albrechtsen S, Dalaker K. Women with a history of placental abruption: when in subsequent pregnancy should special surveillance for a recurrent placental abruption be initiate? Acta Obstet Gynecol Scand. 2001;80(8):708–12.PubMed
34.
Zurück zum Zitat Abu-Heija A, Al-Chalabi H, El-lloubani N. Abruptio placentae: risk factors and perinatal outcome. J Obstet Gynaecol Res. 1998;24(2):141–4.PubMed Abu-Heija A, Al-Chalabi H, El-lloubani N. Abruptio placentae: risk factors and perinatal outcome. J Obstet Gynaecol Res. 1998;24(2):141–4.PubMed
35.
Zurück zum Zitat Hossain NKN, Sultana SS, Khan N. Abruptio placenta and adverse pregnancy outcome. J Pak Med Assoc. 2010;60(6):443–6.PubMed Hossain NKN, Sultana SS, Khan N. Abruptio placenta and adverse pregnancy outcome. J Pak Med Assoc. 2010;60(6):443–6.PubMed
36.
Zurück zum Zitat Thieba B, Lankoande J, Akotionga M, Kyelem C, Ouedraogo A, Ouedraogo CM, et al. Abruptio placentae: epidemiological, clinical and prognostic aspects with respect to a 177 case series. Gynecol Obstet Fertil. 2003;31(5):429–33.PubMed Thieba B, Lankoande J, Akotionga M, Kyelem C, Ouedraogo A, Ouedraogo CM, et al. Abruptio placentae: epidemiological, clinical and prognostic aspects with respect to a 177 case series. Gynecol Obstet Fertil. 2003;31(5):429–33.PubMed
37.
Zurück zum Zitat Ananth CV, Peedicayil A, Savitz DA. Effect of hypertensive diseases in pregnancy on birthweight, gestational duration, and small-or-gestational-age births. Epidemiology. 1995;6(4):391–5.PubMed Ananth CV, Peedicayil A, Savitz DA. Effect of hypertensive diseases in pregnancy on birthweight, gestational duration, and small-or-gestational-age births. Epidemiology. 1995;6(4):391–5.PubMed
38.
Zurück zum Zitat Saeed M, Rana T. Fetomaternal outcome in pregnancies complicated with placental abruption. PJMH. 2011;5(1):1–5. Saeed M, Rana T. Fetomaternal outcome in pregnancies complicated with placental abruption. PJMH. 2011;5(1):1–5.
39.
Zurück zum Zitat Du Toit MM, Smith M, Odendaal HJ. The role of prenatal alcohol exposure in abruptio placentae. S Afr Med J. 2010;100(12):832–5.PubMed Du Toit MM, Smith M, Odendaal HJ. The role of prenatal alcohol exposure in abruptio placentae. S Afr Med J. 2010;100(12):832–5.PubMed
Metadaten
Titel
Frequency, risk factors and feto-maternal outcomes of abruptio placentae in Northern Tanzania: a registry-based retrospective cohort study
verfasst von
Godwin S. Macheku
Rune Nathaniel Philemon
Olola Oneko
Pendo S. Mlay
Gileard Masenga
Joseph Obure
Michael Johnson Mahande
Publikationsdatum
01.12.2015
Verlag
BioMed Central
Erschienen in
BMC Pregnancy and Childbirth / Ausgabe 1/2015
Elektronische ISSN: 1471-2393
DOI
https://doi.org/10.1186/s12884-015-0678-x

Weitere Artikel der Ausgabe 1/2015

BMC Pregnancy and Childbirth 1/2015 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.